韩露露

韩露露，医学博士，讲师。2017年获徐州医科大学肿瘤学硕士学位，2021年获北京大学医学部博士学位，同年9月加入细胞治疗药物产业学院。目前主要从事中性粒细胞在肺癌恶性进展及癌性血栓形成中的机制研究。主持国家自然科学基金青年项目1项、徐州医科大学优秀人才科研启动基金1项；2022年获评江苏省“双创”博士。以第一作者在Research、Cancer Biology & Medicine、Redox Biology、Blood Advances等期刊发表学术论文9篇，获授权中国发明专利1项。

代表论文：

1.Han L¹, Chen Y¹, Wu R, Chen J, Chen Z, Cai Y, Huang S, Gu H, Zhuang X, Lv Y, Li H, Li L*, Wang G*. Tumor-derived exosomal fatty acids reprogram neutrophils to drive neutrophil extracellular traps formation and lung cancer progression. Research (Wash D C). 2026;9:1278.(中科院1区，IF: 12.9)

2.Han L¹, Chen Y, Huang N, Zhou X, Lv Y, Li H, Chai D, Wang G*. Cancer-educated neutrophils promote lung cancer progression via PARP-1-ALOX5-mediated MMP-9 expression. Cancer Biol Med. 2024;21(2):175–92.(中科院2区，IF: 12.4)

3.Han L¹, Du X¹, Yan Y, Zhang L, Feng J*, Wang X*, Zhang X*. Fenofibrate attenuates hyperhomocysteinemia-potentiated thrombosis by restoring platelet fatty acid β-oxidation. Redox Biol. 2026;95:104250.(中科院1区，IF: 16.2)

4.Chen Y¹,Han L¹, Qiu X, Wang M, Chen Z, Cai Y, Xin Y, Lv Y, Hu A, Chai D, Li L, Li H, Wang G*. Reassembling of albumin-bound paclitaxel mitigates myelosuppression and improves its antitumoral efficacy via neutrophil-mediated targeting drug delivery. Drug Deliv. 2022;29(1):728-742.(中科院2区，IF: 7.9)

5.Han L, Miao Y, Zhao Y, Zhang X, Ma X, Du X, Kong W, Xu Q, Liu J, Dai K*, Feng J*, Wang X*. The binding of autotaxin to integrins mediates hyperhomocysteinemia-potentiated platelet activation and thrombosis in mice and humans. Blood Adv. 2022;6(1):46-61.(中科院1区，IF: 7.7)